Subtype
Male Reproductive System Neoplasm
CI-CAN-00001107Explore in graph →
Non-malignant1,536 active trials27 approved drugs58 evidence items
- NCIt
- C3054
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001107Explore in graph →
Clinical trials
6,903 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06856694 | RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer(NLP RCT) | recruiting | N/A | 283 | Cedars-Sinai Medical CenterOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT06877598 | Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patients and Their Partners | recruiting | — | 575 | University Health Network, TorontoOTHER | 1 | Dec 11, 2025 |
| clinicaltrials |
| NCT06943521 | A Study of MT-4561 in Patients With Various Advanced Solid Tumors | recruiting | Phase 1 / Phase 2 | 27 | Tanabe Pharma America, Inc.INDUSTRY | 2 | Dec 11, 2025 | clinicaltrials |
| NCT06105918 | Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer | active not recruiting | Phase 1 | 6 | Emory UniversityOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT07069049 | Electroacupuncture in the Treatment of Patients Undergoing Transperineal Prostate Biopsy Under Local Anesthesia(EATPULA) | not yet recruiting | N/A | 190 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Dec 9, 2025 | clinicaltrials |
| NCT07272317 | PSMA-PET/MRI-Ultrasound Multimodal Fusion Navigation for Da Vinci Robot-Assisted Radical Prostatectomy: A Randomized Controlled Trial | not yet recruiting | N/A | 98 | Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Dec 9, 2025 | clinicaltrials |
| NCT06353906 | Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer(PRIAM) | recruiting | Phase 2 | 27 | The Netherlands Cancer InstituteOTHER | 2 | Dec 8, 2025 | clinicaltrials |
| NCT06637943 | Comparison of the Diagnosis Time of VET and SCL in Patients With Intraoperative Coagulopathy | not yet recruiting | — | 210 | Konkuk University Medical CenterOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07268794 | CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer(CONVERT-HB1) | not yet recruiting | Phase 2 | 112 | Fudan UniversityOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT07271017 | Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe | recruiting | Phase 1 | 60 | Johns Hopkins UniversityOTHER | 1 | Dec 8, 2025 | clinicaltrials |
| NCT06965192 | Designing Visual Tools to Enhance Cancer Surgeon Decision-making | recruiting | N/A | 220 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07115446 | Phase Ib Study of HS-20093+HRS-5041 in Patients With Advanced Prostate Cancer | recruiting | Phase 1 | 63 | Hansoh BioMedical R&D CompanyINDUSTRY | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07266129 | Virtual Biopsy of Prostate Cancer Using PSMA PET and AI | recruiting | — | 220 | University Hospital of North NorwayOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT07268469 | Minimal Residual Disease in Solid Malignancies(IMRD) | not yet recruiting | N/A | 840 | European Institute of OncologyOTHER | 0 | Dec 5, 2025 | clinicaltrials |
| NCT03511196 | Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer | active not recruiting | Early Phase 1 | 17 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT04319146 | Study of Robot-assisted Radical Prostatectomy Performed on Outpatient in Patients With Localized Prostate Cancer(AMBUPRO) | active not recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05189457 | First Strike, Second Strike Therapies for High Risk Metastatic Castration Sensitive Prostate Cancer | active not recruiting | Phase 2 | 32 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05526989 | Study of the Combination Dostarlimab With Niraparib In Patients With Penile Carcinoma | recruiting | Phase 2 | 25 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07180381 | Sequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer(SPROUT) | recruiting | N/A | 503 | St. Antonius HospitalOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT07265414 | DRG Mutations in Prostate Cancer: a Guiding Light for Enhanced Screening and Personalised Therapy | active not recruiting | — | 320 | Istituto Clinico HumanitasOTHER | 1 | Dec 4, 2025 | clinicaltrials |
| NCT05893381 | Lu-PSMA and Stereotactic Radiotherapy Versus Radiotherapy Alone for Prostate Cancer (LUST)(LUST) | recruiting | Phase 2 | 70 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCSOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07260435 | Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer(Apa/Enza-short) | recruiting | Phase 3 | 400 | Nick BeijeOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT07262073 | Comparison of Peak Expiratory Flow Changes After Robot-Assisted Versus Open Radical Prostatectomy | active not recruiting | N/A | 60 | Ankara City Hospital BilkentOTHER | 1 | Dec 3, 2025 | clinicaltrials |
| NCT02341989 | Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer(SWENOTECA-ABC) | active not recruiting | Phase 3 | 348 | St. Olavs HospitalOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT05786716 | DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With HER2 Amplification or Activating Mutations(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT07258056 | GUidance In Prostate Cancer DEtection With 18F-PSMA-1007-PET/MRI and Targeted Biopsies(GUIDE PSMA PET) | recruiting | N/A | 100 | Mads Ryo JochumsenOTHER | 1 | Dec 2, 2025 | clinicaltrials |
| NCT01607008 | MRI for Assessing Prostate Cancer Response(NA_00067284) | active not recruiting | N/A | 38 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT03983954 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. | active not recruiting | Phase 1 | 120 | NeoTX Therapeutics Ltd.INDUSTRY | 2 | Nov 28, 2025 | clinicaltrials |
| NCT03143322 | Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only Metastases(STEREO-OS) | active not recruiting | N/A | 168 | UNICANCEROTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT06200558 | ARON-3 Study: International Multicentric Retrospective Study to Collect Global Experiences in the Treatment of Patients With Metastatic PCa | recruiting | — | 534 | Hospital of MacerataOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07250542 | A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer | recruiting | Phase 2 | 30 | baotai LiangOTHER | 1 | Nov 26, 2025 | clinicaltrials |
| NCT07251829 | Neoadjuvant Embolization and Cytoreduction in Prostate Cancer | not yet recruiting | Phase 2 | 35 | Srinivas RamanOTHER | 0 | Nov 26, 2025 | clinicaltrials |
| NCT01961713 | Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing Prostatectomy | recruiting | — | 200 | Massachusetts General HospitalOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT02023463 | Enzalutamide, Radiation Therapy and Hormone Therapy in Treating Patients With Intermediate or High-Risk Prostate Cancer | active not recruiting | Phase 1 | 25 | Thomas Jefferson UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT05696444 | Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO) | active not recruiting | N/A | 144 | Medtronic - MITGINDUSTRY | 1 | Nov 25, 2025 | clinicaltrials |
| NCT06400160 | Clinical Trial of TB511 in Advanced Solid Tumors | not yet recruiting | Phase 1 / Phase 2 | 12 | Twinpig Biolab, Inc.INDUSTRY | 0 | Nov 25, 2025 | clinicaltrials |
| NCT07249281 | MR Microstructural Imaging for Prostate Cancer Diagnosis | recruiting | — | 2,000 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Nov 25, 2025 | clinicaltrials |
| NCT01653925 | Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression | active not recruiting | N/A | 120 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05384535 | Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | recruiting | N/A | 100 | Northwell HealthOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05739565 | Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients(ACTI-PAIR2) | recruiting | N/A | 850 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05965180 | Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe | recruiting | — | 50 | University of Michigan Rogel Cancer CenterOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | recruiting | Phase 1 / Phase 2 | 39 | Institute of Cancer Research, United KingdomOTHER | 2 | Nov 24, 2025 | clinicaltrials |
| NCT07106827 | A Study of GV20-0251 in Advanced or Refractory Solid Tumors | recruiting | Phase 1 | 10 | West China HospitalOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT07244393 | Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer | not yet recruiting | Phase 1 | 30 | Cellbion Co., Ltd.INDUSTRY | 0 | Nov 24, 2025 | clinicaltrials |
| NCT07245342 | Electroacupuncture for Improving Urinary Incontinence After Radical Prostatectomy(EA) | not yet recruiting | N/A | 216 | Shanghai University of Traditional Chinese MedicineOTHER | 0 | Nov 24, 2025 | clinicaltrials |
| NCT05238883 | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors | active not recruiting | Phase 1 | 72 | HiFiBiO TherapeuticsINDUSTRY | 2 | Nov 21, 2025 | clinicaltrials |
| NCT05743621 | Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer | recruiting | Phase 1 | 30 | Weill Medical College of Cornell UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT07242014 | 68Ga-XACP3 PET/CT in Prostate Cancer | recruiting | N/A | 60 | The First Affiliated Hospital of Xiamen UniversityOTHER | 1 | Nov 21, 2025 | clinicaltrials |
| NCT02333435 | Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life(RCT-EPA) | active not recruiting | Phase 2 | 130 | CHU de Quebec-Universite LavalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT07238959 | Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer | not yet recruiting | — | 1,100 | Shanghai Changzheng HospitalOTHER | 1 | Nov 20, 2025 | clinicaltrials |
Data updated 24 days agoSource updated Dec 11, 2025source: clinicaltrials